Cullgen Funding & Investors
Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
cullgen.comTotal Amount Raised: $106,000,000
Cullgen Funding Rounds
Corporate Round
$5,000,000
Corporate Round Investors
GNI GroupSeries C
$35,000,000
Series C Investors
Sincere CapitalAstraZeneca-CICC Venture CapitalGNI GroupWuxi CapitalVoyagers CapitalSeries B
$50,000,000
Series B Investors
Heights Capital Management3E Bioventures CapitalSouth China Venture CapitalOctagon Capital AdvisorsMSA CapitalSeries A
$16,000,000
Series A Investors
Sequoia ChinaHighLight Capital
Funding info provided by Diffbot.